Literature DB >> 15814689

Fetal expression of Fas ligand is necessary and sufficient for induction of CD8 T cell tolerance to the fetal antigen H-Y during pregnancy.

Melanie S Vacchio1, Richard J Hodes.   

Abstract

Interaction of Fas with Fas ligand (FasL) is known to play a role in peripheral tolerance mediated by clonal deletion of Ag-specific T cells. We have assessed the requirement for Fas/FasL interactions during induction of tolerance to the fetus. Using H-Y-specific TCR transgenic mice, we have previously demonstrated that exposure of maternal T cells to H-Y expressed by male fetuses results in deletion of 50% of H-Y-specific maternal T cells. The remaining H-Y-specific T cells were hyporesponsive to H-Y as assayed by decreased proliferative ability and CTL activity. To determine whether Fas/FasL interactions contribute to induction of maternal T cell tolerance, responsiveness to fetal H-Y was assessed in H-Y-specific TCR transgenic pregnant females that were deficient in functional Fas or FasL. Surprisingly, both deletion and nondeletion components of tolerance were abrogated in TCR transgenic H-Y-specific lpr (Fas-deficient) or gld (FasL-deficient) pregnant females. Experiments further revealed that expression of FasL by the fetus, but not by the mother, is necessary and sufficient for both components of maternal T cell tolerance to fetal Ags. Fas interaction with fetal FasL is thus critical for both deletion and hyporesponsiveness of H-Y-reactive CD8+ T cells during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15814689     DOI: 10.4049/jimmunol.174.8.4657

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Transient modification within a pool of CD4 T cells in the maternal spleen.

Authors:  Elizabeth A Bonney; Michelle T Shepard; Peyman Bizargity
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  An immunogenic phenotype in paternal antigen-specific CD8+ T cells at embryo implantation elicits later fetal loss in mice.

Authors:  Lachlan M Moldenhauer; Kerrilyn R Diener; John D Hayball; Sarah A Robertson
Journal:  Immunol Cell Biol       Date:  2017-05-22       Impact factor: 5.126

3.  Evidence that CD8 T-cell homeostasis and function remain intact during murine pregnancy.

Authors:  Michelle T Norton; Karen A Fortner; Karen H Oppenheimer; Elizabeth A Bonney
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

Review 4.  T cell recognition and immunity in the fetus and mother.

Authors:  Cody A Koch; Jeffrey L Platt
Journal:  Cell Immunol       Date:  2007-10-24       Impact factor: 4.868

Review 5.  The hidden maternal-fetal interface: events involving the lymphoid organs in maternal-fetal tolerance.

Authors:  Elizabeth S Taglauer; Kristina M Adams Waldorf; Margaret G Petroff
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

6.  T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1.

Authors:  Hernan D Kopcow; Florencia Rosetti; Yiuka Leung; David S J Allan; Jeffrey L Kutok; Jack L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-14       Impact factor: 11.205

7.  Maternal PD-1 regulates accumulation of fetal antigen-specific CD8+ T cells in pregnancy.

Authors:  Elizabeth S Taglauer; Thomas M Yankee; Margaret G Petroff
Journal:  J Reprod Immunol       Date:  2009-04-14       Impact factor: 4.054

8.  Dendritic cells: a family portrait at mid-gestation.

Authors:  Peyman Bizargity; Elizabeth A Bonney
Journal:  Immunology       Date:  2008-09-05       Impact factor: 7.397

9.  PD-1 regulates T cell proliferation in a tissue and subset-specific manner during normal mouse pregnancy.

Authors:  Michelle T Shepard; Elizabeth A Bonney
Journal:  Immunol Invest       Date:  2013-06-19       Impact factor: 3.657

10.  CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties.

Authors:  Zhou Xin Yang; Zhi-Bo Han; Yue Ru Ji; You Wei Wang; Lu Liang; Ying Chi; Shao Guang Yang; Li Na Li; Wei Feng Luo; Jian Ping Li; Dan Dan Chen; Wen Jing Du; Xiao Cang Cao; Guang Sheng Zhuo; Tao Wang; Zhong Chao Han
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.